Article Details

iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval

Retrieved on: 2021-06-14 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval. View article details on hiswai:

Excerpt

(NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ProFound AI® ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up